for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Moderna Inc

MRNA.O

現在値

333.01USD

変化

-0.60(-0.18%)

出来高

4,983,215

本日のレンジ

329.36

 - 

338.60

52週レンジ

65.49

 - 

497.49

∙ 約20分前の相場を表示しています。

適時開示

FDA Delays Moderna Covid-19 Vaccine For Adolescents To Review Rare Myocarditis Side Effect - WSJ

Oct 15 (Reuters) - :FDA DELAYS MODERNA COVID-19 VACCINE FOR ADOLESCENTS TO REVIEW RARE MYOCARDITIS SIDE EFFECT - WSJ.

Moderna Inc Announces Covax Exercises Option To Purchase 176.5 Mln Additional Doses Of Moderna’S COVID-19 Vaccine For Low Income Countries

Oct 12 (Reuters) - Moderna Inc <MRNA.O>::MODERNA ANNOUNCES COVAX EXERCISES OPTION TO PURCHASE 176.5 MILLION ADDITIONAL DOSES OF MODERNA’S COVID-19 VACCINE FOR LOW INCOME COUNTRIES IN FIRST HALF OF 2022.MODERNA INC - COVAX HAS OPTIONS TO PURCHASE AN ADDITIONAL 233 MILLION DOSES IN SECOND HALF OF 2022.MODERNA INC - REQUESTED AUTHORIZATION OF A 50 ΜG BOOSTER DOSE FROM GLOBAL REGULATORS.MODERNA INC - 116.5 MILLION DOSES ARE EXPECTED TO BE DELIVERED IN Q1 OF 2022 AND 60 MILLION DOSES ARE EXPECTED TO BE DELIVERED IN Q2 OF 2022.MODERNA - MORE THAN 210 MILLION DOSES HAVE NOW BEEN PURCHASED BY COVAX FOR DELIVERY TO LOW INCOME COUNTRIES, INCLUDING 34 MILLION DOSES TO BE DELIVERED IN Q4.MODERNA -THROUGH LONG-TERM AGREEMENT, UNICEF, ITS PROCUREMENT PARTNERS PROVIDED ACCESS TO UP TO 500 MILLION DOSES OF MODERNA COVID-19 VACCINE THROUGH 2022.MODERNA INC - IN DISCUSSIONS TO ALLOCATE AND SUPPLY COVID-19 VACCINE TO SELF-FINANCING PARTICIPANTS IN FUTURE.

U.S. CDC ACIP To Meet On Oct. 20-21 To Discuss Covid-19 Vaccine Boosters For Modern, J&J

Oct 8 (Reuters) - U.S. CDC :CDC - INDEPENDENT ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES PLANS TO MEET ON OCT. 20-21 TO DISCUSS COVID-19 VACCINE BOOSTERS FOR MODERN, J&J.CDC - ACIP WILL MEET ON NOVEMBER 2-3 TO DISCUSS PEDIATRIC COVID-19 VACCINATION.Further company coverage: JNJ.N. ((Reuters.Briefs@thomsonreuters.com;)).

EMA Recommends Pfizer, Moderna Vaccine Booster For Those With Weak Immunity

Oct 4 (Reuters) - European Medicines Agency (EMA)::EMA:COMIRNATY AND SPIKEVAX: EMA RECOMMENDATIONS ON EXTRA DOSES AND BOOSTERS.EMA: EXTRA DOSE OF THE COVID-19 VACCINES COMIRNATY (BIONTECH/PFIZER) AND SPIKEVAX (MODERNA) MAY BE GIVEN TO PEOPLE WITH SEVERELY WEAKENED IMMUNE SYSTEMS.EMA SAYS CONCLUDED EXTRA DOSE OF COVID-19 VACCINES COMIRNATY AND SPIKEVAX MAY BE GIVEN TO PEOPLE WITH SEVERELY WEAKENED IMMUNE SYSTEMS, AT LEAST 28 DAYS AFTER SECOND DOSE.EMA: EXPECTED THAT EXTRA DOSE OF COVID-19 VACCINES 'WOULD INCREASE PROTECTION AT LEAST IN SOME PATIENTS'.EMA SAYS IMPORTANT TO DISTINGUISH BETWEEN EXTRA DOSE FOR PEOPLE WITH WEAKENED IMMUNE SYSTEMS AND BOOSTER DOSES FOR PEOPLE WITH NORMAL IMMUNE SYSTEMS.EMA SAYS RISK OF INFLAMMATORY HEART CONDITIONS OR OTHER VERY RARE SIDE EFFECTS AFTER A BOOSTER IS NOT KNOWN AND IS BEING CAREFULLY MONITORED.EMA SAYS COMMITTEE IS CURRENTLY EVALUATING DATA TO SUPPORT A BOOSTER DOSE FOR SPIKEVAX.EMA: PFIZER VACCINE BOOSTER MAY BE CONSIDERED AT LEAST 6 MTHS AFTER SECOND DOSE FOR PEOPLE AGED 18 YEARS AND OLDER WITH NORMAL IMMUNE SYSTEMS.Further company coverage: [22UAy.DE]PFE.NMRNA.O. ((Reuters.Briefs@thomsonreuters.com;)).

EMA Says EC Issues Decision Renewing Conditional Marketing Authorisation For Moderna Covid-19 Vaccine

Oct 4 (Reuters) - European Medicines Agency::EMA: EUROPEAN COMMISSION ISSUED A DECISION RENEWING CONDITIONAL MARKETING AUTHORISATION FOR MODERNA COVID-19 VACCINE.Further company coverage: MRNA.O. ((Reuters.Briefs@thomsonreuters.com;)).

FDA Won't Extend Shelf Life Of J&J Covid Vaccine Doses, May Extend Life Of Millions Of Moderna Shots - NBC News

Oct 1 (Reuters) - :FDA WON'T EXTEND SHELF LIFE OF J&J COVID VACCINE DOSES, MAY EXTEND LIFE OF MILLIONS OF MODERNA SHOTS - NBC NEWS.FDA EXTENSION FOR MODERNA VACCINE DOSES WOULD LIKELY ADD UP TO TWO MONTHS TO THE LIFE OF VACCINE DOSES - NBC NEWS.Further company coverage: JNJ.N. ((Reuters.Briefs@thomsonreuters.com;)).

Alexandria Real Estate Expands Relationship With Moderna For New 462,000 RSF HQ, R&D Facility

Sept 30 (Reuters) - Alexandria Real Estate Equities Inc <ARE.N>::ALEXANDRIA REAL ESTATE EQUITIES, INC. DEEPENS AND EXPANDS STRATEGIC RELATIONSHIP WITH MODERNA FOR NEW 462,000 RSF HQ AND RESEARCH AND DEVELOPMENT FACILITY AT 325 BINNEY STREET, DESIGNED TO BE THE MOST SUSTAINABLE LABORATORY BUILDING IN CAMBRIDGE.ALEXANDRIA REAL ESTATE EQUITIES - MODERNA HAS SELECTED ALEXANDRIA TO DEVELOP, OPERATE AND CONSTRUCT NEW CORPORATE HEADQUARTERS AND CORE RESEARCH AND DEVELOPMENT FACILITY.

Moderna Announces Health Canada Approves Its COVID-19 Vaccine

Sept 16 (Reuters) - Moderna Inc <MRNA.O>::MODERNA ANNOUNCES HEALTH CANADA APPROVES ITS COVID-19 VACCINE.MODERNA - HEALTH CANADA APPROVED NEW DRUG SUBMISSION FOR SPIKEVAX BASED ON DATA FROM PHASE 3 COVE STUDY OF MODERNA COVID-19 VACCINE.MODERNA - HEALTH CANADA APPROVED NEW DRUG SUBMISSION FOR SPIKEVAX FOR ACTIVE IMMUNIZATION TO PREVENT COVID-19 IN INDIVIDUALS 12 YRS AND OLDER.

Moderna Highlights New Clinical Data On Its Covid-19 Vaccine

Sept 15 (Reuters) - Moderna Inc <MRNA.O>::MODERNA HIGHLIGHTS NEW CLINICAL DATA ON ITS COVID-19 VACCINE.MODERNA INC - MRNA-1273 REMAINS HIGHLY EFFECTIVE AGAINST COVID-19 IN REAL-WORLD EFFECTIVENESS STUDY DURING SURGE IN DELTA CASES.MODERNA INC - MRNA-1273 REMAINS HIGHLY EFFECTIVE AGAINST COVID-19 IN REAL-WORLD EFFECTIVENESS STUDY DURING SURGE IN DELTA CASES.MODERNA INC - COMPANY BELIEVES DATA SUPPORT BENEFIT OF AN MRNA-1273 BOOSTER DOSE.MODERNA - ANALYSIS OF OPEN-LABEL PORTION OF PHASE 3 COVE STUDY SHOWS LOWER RISK OF BREAKTHROUGH INFECTION IN PARTICIPANTS VACCINATED MORE RECENTLY.

AbCellera Reports Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines

Sept 15 (Reuters) - Abcellera Biologics Inc <ABCL.O>::ABCELLERA ANNOUNCES COLLABORATION WITH MODERNA TO DISCOVER THERAPEUTIC ANTIBODIES FOR MRNA MEDICINES.ABCELLERA BIOLOGICS INC - ENTERED INTO A MULTI-YEAR, MULTI-TARGET RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH MODERNA.ABCELLERA BIOLOGICS INC - UNDER TERMS OF AGREEMENT, MODERNA WILL HAVE RIGHTS TO DEVELOP AND COMMERCIALIZE ANTIBODIES RESULTING FROM COLLABORATION.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up